• 제목/요약/키워드: Patient with Head and Neck Cancer

검색결과 234건 처리시간 0.029초

두경부암 세기변조방사선치료 계획 시 부분적 고에너지 광자선 사용에 따른 치료계획 평가 (The Effect of Partially Used High Energy Photon on Intensity-modulated Radiation Therapy Plan for Head and Neck Cancer)

  • 장남준;석진용;원희수;홍주완;최지훈;박진홍
    • 대한방사선치료학회지
    • /
    • 제25권1호
    • /
    • pp.1-8
    • /
    • 2013
  • 목 적: 체내에서 광자선은 에너지에 따라 다른 선량분포 특성을 보이기 때문에 치료계획 시 적절한 에너지 선택이 중요하다. 두경부암 세기변조방사선치료(intensity modulated radiation therapy, IMRT)는 주로 저에너지 광자선을 사용하는데, 본 연구에서는 후사방향 조사면에 부분적으로 고에너지 광자선을 사용하였을 때 치료계획에 미치는 영향을 알아보고자 한다. 대상 및 방법: 본원에서 두경부암 세기변조방사선치료를 시행한 10명(nasopharyngeal carcinoma 5, tonsilar carcinoma 5)의 환자를 대상으로 하였다. 동일한 조건하에 환자의 CT영상을 3 mm 두께로 획득하고 치료계획시스템은 Eclipse (Ver 7.1, Varian, Palo Alto, USA)를 사용하였다. 환자마다 8개 조사면으로 6 MV 에너지를 사용한 치료계획(low energy plan, LEP)과 상대적으로 투과 깊이가 깊은 후사방향의 2개 조사면에서 15 MV 에너지를 사용한 치료계획(partially used high energy plan, PHEP)을 각각 수립하였으며, 다른 치료계획조건들과 plan normalization은 동일하게 적용하였다. 수립된 치료계획을 평가하기 위해서 계획표적체적(planning target volume, PTV)의 coverage, conformity index (CI), homogeneity index (HI)를 비교하였고 양측 이하선의 $D_{mean}$, $D_{50%}$와 뇌척수의 $D_{max}$, $D_{1%}$ 그리고 integral dose (ID)를 비교하였다. 특히, 후경부의 정상조직선량을 비교하기 위해 posterior-normal tissue volume (P-NTV)을 설정하고 dose volume histogram (DVH)을 통해서 $D_{mean}$, $V_{20Gy}$, $V_{25Gy}$를 평가하였으며, 또한 총 monitor unit (MU)의 변화를 비교하였다. 결 과: LEP와 PHEP 사이에서 PTV의 coverage 그리고 CI의 차이는 크지 않았고, HI는 변화없이 전체적으로 동일하게 나타났다. 뇌척수의 선량변화는 크지 않았지만 양측 이하선의 $D_{mean}$, $D_{50%}$ 그리고 ID는 PHEP에서 각각 0.6%, 0.7%, 1.1% 감소하였다. P-NTV의 $D_{mean}$, $V_{20Gy}$, $V_{25Gy}$는 PHEP에서 각각 1.6%, 1.8%, 2.9% 감소하였고, 총 MU도 평균 1.8% 감소하였다. 결 론: 본 연구결과 후사방향에서 부분적으로 고에너지를 사용한 치료계획에서 일부 결정장기(organ at risk, OAR)와 정상조직의 선량, 그리고 총 MU를 감소시키는 효과가 있었다. 이런 효과가 환자에게 임상적으로 얼마나 이로운지는 명확하지 않지만, 두경부암 세기변조방사선치료 계획 시 부분적으로 고에너지 광자선을 사용하는 것은 치료계획의 전반적인 질을 개선하는 데 유용 할 것으로 본다.

  • PDF

후두 전 절제 환자에서 음성재활을 위한 기관식도발성 (Tracheoesophageal Shunt Voice in Total Laryngectomee)

  • 왕수건;장선미
    • 대한후두음성언어의학회지
    • /
    • 제19권1호
    • /
    • pp.21-27
    • /
    • 2008
  • Total laryngectomy is the most useful procedure tor advanced laryngopharyngeal cancer, but it remains the major problem such as loss of voice. Voice restoration is essential for every patients who undergo a total laryngectomy. Ideal voice rehabilitation methods can resolve three factors. First, every laryngectomee can produce voice sufficient for communication, second every patient should be allowed to use both hands freely during phonation, and last, the voice restoration methods should be easy and safe without complication during and after treatment. Among various voice rehabilitation procedures during or after total laryngectomy, it can be divided electronic and pneumatic methods. In pneumatic methods, there are also divided both pulmonary air and non-pulmonary air methods. The non-pulmonary air methods include esophageal speech, buccal speech, and pharyngeal speech. Pulmonary air methods are divided into surgical and non-surgical such as pneumatic speech aid. In the surgical methods, there are neoglottic operation, tracheopharyngeal shunt, and tracheopharyngeal shunt operations. Recently, tracheoesophageal shunt with or without prosthesis are being recognized the most effective method. Blom-Singer low pressure prosthesis, Panje button, and Provox are well known types of prosthesis in the tracheoesophageal shunt operation. Amatsu method is a kind of famous tracheoesophageal shunt method without using prosthesis. Authors tried to review the published articles for evaluation of effectiveness and problems of tracheoesophageal shunt operation with or without prosthesis. In conclusion, indwelling type of prosthesis and pharyngeal myotomy and plexus neurectomy are recommended for higher success rate during tracheoesophageal puncture procedure. More over, Amatsu method is also one of the recommended voice rehabilitation procedure during total laryngectomy. In this situation, pharyngeal myotomy and plexus neurectomy may be helpful for better fluent communication.

  • PDF

갑상선 암의 판정에 대한 술전 초음파의 의의 (Diagnostic Value of Preoperative Ultrasonographic Evaluation on Thyroid Cancer)

  • 윤길훈;류기선;정진영;조재현;김명욱;소의영
    • 대한두경부종양학회지
    • /
    • 제15권1호
    • /
    • pp.66-69
    • /
    • 1999
  • Background and Objectives: It is critical to distinguish benign from malignant thyroid nodule and to select a patient for surgery. Even though the U/S study dose not make great contribution to diagnose a malignant thyroid nodule, it is widely used in the evaluation of anatomic feature of thyroid. The authors tried to estimate the efficacy of the U/S study in preoperative diagnosis of malignant thyroid nodule. Materials and Method: At the department of General Surgery of Ajou University, 75 patients who were operated after diagnosis with thyroid nodule by U/S study between July 1996 to June 1997 were retrospectively analyzed. By comparing the U/S impression that implies malignant thyroid nodule to FNAC and post-operative pathologic results ware as follows. Results: 1) Absence of cystic change, presence of internal hypoechogenicity, lobulation, calcification, thick and irregular halo, and nodule more than 4cm in diameter on U/S were considered significant statistically for the diagnosis of malignancy(Chi-square test, p<0.05) 2) Presence of internal hypoechogenicity or thick and irregular halo has the validity in Logistic regression analysis. 3) FNAC was done in 65 case. 19 case were malignant, 11 case were suspicious and 46 patients were benign (sensitivity 52.6%, specificity 87%). 4) The findings of U/S which are hypoechogenic and thick and irregular halo show 82% sensitivity and 97% specificity. In combination with the findings of FNAC that imply benign or suspicious lesions, the sensitivity was 100% and the specificity was 97%. Conclusion: This study suggest that the hypoechogenicity and thick and irregular halo on U/S are important information for the diagnosis of thyroid malignancy which were considered benign or suspicious after FNAC.

  • PDF

국소 진행된 비인강암의 방사선-항암제 병용요법 (Radiation Therapy Combined with Cisplatin Based Chemotherapy for the Patients with Locally Advanced Nasopharyngeal Cancer)

  • 손석현;김지윤;김성환;문성권;조승호;박영학;홍영선;김연실
    • 대한두경부종양학회지
    • /
    • 제22권2호
    • /
    • pp.123-129
    • /
    • 2006
  • Objective : This retrospective study was designed to evaluate the anti-tumor efficacy and toxicities of the radiation therapy(RT) combined with cisplatin-based chemotherapy in locally advanced nasopharyngeal cancer(NPC). Materials and Methods : Fifty three patients with locally advanced NPCs(AJCC stage II, III, IV) received curative RT and cisplatin-based chemotherapy. Duration of follow-up ranged from 5.5 to 201 months(median 50.8 months). Nineteen patients(35.8%) were treated with induction chemotherapy including cisplatin $100mg/m^2$ for 1 day and 5-fluorouracil $1g/m^2$ for 5 days followed by RT(Induction CTx-RT). Another 34 patients (64.2%) were treated with concurrent chemoradiation(CCRT) using cisplatin $100mg/m^2$(D1, 22, 43). Results : Thirty-six(67.9%) and 11(20.8%) patients achieved clinical complete response and partial response, respectively. The pattern of failure was as follows:14 locoregional recurrence(26.4%) and 7 distant metastasis(13.2%). Among them, two patients(3.8%) had both locoregional and distant failure. Median overall survival(OS) and progression-free survival(PFS) were 85.5 months and 87.5 months, respectively. Five-year OS rate was 57.1%. The stage(AJCC), tumor response to chemoradiation and T stage were significant prognostic factors for OS(p=0.0113, p=0.0362 and p=0.0469). The stage(AJCC), tumor response to chemoradiation were also significant prognostic factors for PFS(p=0.0329, p=0.0424). Compared to each treatment group(Induction CTx-RT vs. CCRT), there were no significant differences in OS and PFS(p=0.7000, p=0.8261). Grade 3-4 mucositis, nausea/vomiting and hematological toxicities were noticed in 35.8%, 11.3% and 13.2%, respectively. Delayed RT over 2 weeks was inevitable in 26.5%. Seventeen patients(50%) successfully completed planned 3 courses of cisplatin in CCRT group. Conclusions : RT combined with cisplatin-based chemotherapy in locally advanced NPC showed high response rate, good locoregional control, and survival rate. As expected, frequency of acute toxicities increased, and the patient's compliance to treatment was need to be improved. Although our data could not show additional survival benefit of CCRT compare to that of induction chemotherapy followed by RT, patients' accrual and further follow-up are required due to limitation of retrospective study.

성인형 스틸씨 병에서 병발된 비인두암의 치료 및 문헌 고찰 (A Case Report and Literature Review : Treatment of Nasopharyngeal Cancer(NPC) Patient with AOSD(Adult Onset Still's Disease))

  • 김준영;김진동;이경빈;이원재;나건웅;박원일;박기철;김태규;지준호
    • 대한두경부종양학회지
    • /
    • 제30권1호
    • /
    • pp.15-19
    • /
    • 2014
  • 비인두암에서 시행되는 방사선 치료 이후에 구강건조증과 피부 변화는 흔하게 볼 수 있는 합병증 중 하나이다. 비인두암의 좋은 예후를 고려할 때, 그러한 치료와 관련된 독성들은 상대적으로 오랫동안 문제를 야기하며 삶의 질 저하를 불러온다. 특히 류마티스 관절염, 루푸스와 같은 결합조직 질환을 가진 환자들에게서 방사선 치료를 시행하였을 때, 빈번하게 심각한 독성이 관찰된다. 본 증례는 성인형 스틸씨 병에서 병발된 비인두암의 치료로 항암방사선 동시치료를 실시한 결과, 비교적 경미한 구강 건조, 점막염, 불면증 등의 합병증이 관찰되었으나, 완전 관해가 획득되었다. 이에 저자들은 과거에 보고된 적 없는 성인형 스틸씨 병에 병발한 비인두암의 치료 경험을 다른 결합조직질환들에서 방사선 치료의 문헌들과 함께 보고하는 바이다.

두경부 암환자 치료 시 CT On-rail System을 이용한 이하선의 위치 보정 및 선량 평가 (Evaluation of Dose and Position Compensation of Parotid Gland Using CT On-rail System in Head-and-Neck Cancer)

  • 장형준;임충근;천금성;정일선;김회남
    • 대한방사선치료학회지
    • /
    • 제20권2호
    • /
    • pp.83-89
    • /
    • 2008
  • 목 적: 두경부 암 환자 치료 시 표적 및 주변 장기(Target 및 Structure)를 확인하는 방법으로 MVCBCT, KVCBCT, CT On-rail System, Ultrasound 등이 이용된다. 이 중 MVCBCT의 경우는 뼈를 이용한 표적 및 주변 장기의 확인에는 유용하나, 연부조직으로 구성된 표적 및 주변 장기의 확인에는 어려움이 있다. 이에 본 연구에서는 CT On-rail System을 이용하여 두경부 암 환자의 이하선의 움직임에 대한 파악과 체적의 변화에 따른 선량의 변화를 연구해 보고자 한다. 대상 및 방법: 본원에서 두경부 암으로 치료받는 환자 5명을 대상으로 하였다. 선택된 환자는 시멘스사 ARTISTE CT Vision (CT On-rail System)을 이용하여 주당 3회씩 CT 스캔을 시행하였다. CT 스캔 후 이하선의 움직임을 치료 계획시의 영상과 비교하여 이동된 좌표를 얻었으며, 이하선의 체적을 확인하기 위하여 획득한 CT영상을 치료계획 시스템(RTP System)에 전송하여 변화된 체적에 따른 선량분포의 차이를 확인하였다. 결 과: 이하선의 움직임에 의한 표적 좌표의 변화는 X: -0.4~0.4 cm, Y: -0.4~0.3 cm, Z: -0.3~0.3 cm이었다. GTV의 체적은 평균 7.11%/week로 감소되었으며 이하선의 체적과 선량의 변화는 평균적으로 좌측 이하선의 체적은 평균 4.81%/week, 우측 이하선의 체적은 2.91%/week, 선량은 좌측 이하선의 선량은 3.66%/week, 우측 이하선 선량은 2.01%/week 감소하였다. 결 론: CT On-rail System에서 얻어진 영상을 이용하여 표적 및 주변 장기를 확인한 결과 MVCBCT를 이용한 영상에 비해 연부조직의 관찰에 우수함을 알 수 있었다. 또한, 획득한 영상으로 재 치료계획(Replanning)을 한 후 선량의 재분포를 획득한 결과 단순한 움직임의 보정뿐 아니라 체적의 변화를 고려한 정확한 선량분포를 얻을 수 있었으며, 이렇게 보정된 선량의 전달은 Adaptive Targeting Radiotherapy가 가능할 수 있다고 사료된다. 향후 선량의 전달까지 걸리는 시간을 단축할 수 있는 Real Time Adaptive Targeting Radiotherapy가 구축되어야 할 것으로 사료된다.

  • PDF

Extraordinarily aggressive cutaneous sarcomatoid squamous cell carcinoma of the face: a case report

  • Lee, Yunjae;Lee, Dongkyu;Yeo, Hyeonjung;Park, Hannara;Park, Hyochun
    • 대한두개안면성형외과학회지
    • /
    • 제23권2호
    • /
    • pp.77-82
    • /
    • 2022
  • Sarcomatoid squamous cell carcinoma (SSCC), a biphasic malignant tumor consisting of atypical squamous epithelial and mesenchymal elements mixed with epithelioid and spindle cells, is a variant of squamous cell carcinoma. Cutaneous SSCC is very rare and aggressive and has a poor prognosis. Here, we report a case of cutaneous SSCC with satellites and in-transit metastases. A 79-year-old woman presented with a protruding mass on the left temporal area sized 1.2×1.0 cm. The punch biopsy report indicated keratoacanthoma or well-differentiated squamous cell carcinoma. The size of the tumor increased to 2.7×2.0 cm after 8 days. An excisional biopsy was performed with a 2 mm safety margin. The tumor was identified as SSCC with a clear resection margin. Reoperation was performed thrice with an increased safety margin of 10 mm; however, the cancer recurred along with satellites and in-transit metastases. Chemoradiotherapy was administered; however, the size of the tumor increased along with satellites and in-transit metastases. The patient expired 162 days after the initial excision. Complete excision and immediate multidisciplinary approach should be combined during the early stages due to the aggressiveness and poor prognosis of cutaneous SSCC with satellites and in-transit metastasis.

소아에서의 갑상선 종양 - 수술적 체험 예들의 임상 고찰 - (Thyroid Tumors in Children - Review of Surgically Treated Cases -)

  • 양성환;김갑태;오성수;정을삼
    • 대한두경부종양학회지
    • /
    • 제14권1호
    • /
    • pp.54-60
    • /
    • 1998
  • Objectives: We'd like to give help in diagnosis and treatment of children's thyoid tumor through our clinical experiences and reference consideration. Materials and Methods: The authors report their experiences with 33 cases of thyroid tumor in patients younger than 16 years of age who were treated at Presbyterian Medical Center from 1979 to 1995. Results: 1) Girls were more predominant than boys by a ratio of 5.6:1. The peak incidence was in the 15 years old of age. 2) The final diagnosis in the 33 patients were thyroid carcinoma in 12 cases, nodular goiter in 6 cases, adenoma in 6 cases, Graves disease in 4 cases, Hasimoto's disease in 4 cases and cyst in 1 case. 3) All of 12 patients with thyroid cancer had nodular tumor. 4) In 5 of 6 patients with palpable cervical lymphadenopathy, the final diagnosis was thyroid carcinoma. 5) Delayed diagnosis arose in 6 of 12 thyroid carcinomas which were treated for long periods as benign disease. 6) The surgical procedures were total thyroidectomy in 3 cases, subtotal thyroidectomy in 13 cases and thyroid lobectomy in 17 cases. 7) 11 of 12 patients with thyroid carcinoma had subtotal or total thyroidectomy with lymphnode dissection and only one had lobectomy. 8) The overall rate of postoperative complication was 3%(1 of 33 patient). 9) Postoperative $^{131}I$ therapy was done in 7 case because of recurrence and distant metastasis in six and severe local invasion in one. 10) In thyroid cancer, the metastatic rate of lymph node at initial surgery was 81%(9/11) and rate of recurrence was 50%(6/12). 11) Patients with thyroid carcinoma were followed up for a mean of 12 years but only one died as a result of thyroid carcinoma 3.5 years later. Conclusion: The authors suggest that thyroid tumors in childhood should receive the benifit of joint management by endocrine pediatrician and experianced surgeons with an agreed protocol of diagnosis and management. We, also, recommend aggressive surgical and $^{131}I$ treatment as the most effective regimen for children with thyroid carcinoma.

  • PDF

비인강암의 세기조절방사선치료기술을 이용한 동시차등조사가속치료의 예비성적 ('Simultaneous Modulated Accelerated Radiation Therapy' (SMART) Intensity-Modulated Radiotherapy in the Treatment of Nasopharyngeal Carcinoma : the Asan Medical Center)

  • 이상욱;백금문;이병용;최은경;김종훈;안승도;신성수;김상윤;남순열;최승호;김성배;송시열
    • 대한두경부종양학회지
    • /
    • 제19권1호
    • /
    • pp.9-15
    • /
    • 2003
  • Purpose: To introduce our early experience with intensity-modulated radiotherapy (IMRT) in the treatment of nasopharyngeal carcinoma. Methods and Materials: Eight patients who underwent IMRT for no disseminated nasopharyngeal carcinoma at the Asan Medical Center between September 2001 and November 2002 were evaluate by prospective analysis. According to the 1997 American Joint Committee on Cancer staging classification, 5 had Stage III, and 3 had Stage IVB disease. The IMRT plans were designed to be delivered as a 'Simultaneous Modulated Accelerated Radiation Therapy' (SMART) using the 'step and shoot' technique with a MLC (multileaf collimator). Daily fractions of 2.2-2.5Gy and 1.9-2Gy were prescribed and delivered to the GTV and CTV and clinically negative neck node, respectively. The prescribed dose was 70A-79.0Gy to the gross tumor volume (GTV), 60Gy to the clinical target volume (CTV) and metastatic nodal station, and 46Gy to the clinically negative neck. All patients also received weekly cisplatin during radiotherapy. Acute and late normal tissue effects were graded according to the Radiation Therapy Oncology Group (RTOG) radiation morbidity scoring criteria. Results: Follow-up period was ranging from 5 to 18 months. All patients showed complete response and loco-regional control rate was 100% but one patient died of malnutrition due to treatment related toxicity. There were no Grade 3 or 4 xerostomia and all patients had experienced improvement of salivary gland function. Conclusion: 'Simultaneous Modulated Accelerated Radiation Therapy' (SMART) boost intensity-modulated radiotherapy technique allows parotid sparing as evidenced both clinically and by dosimetry. Initial tumor response and loco-regional control was promising. It is clinically feasible. A larger population of patients and a long-term follow-up are needed to evaluate ultimate tumor control and late toxicity.

임상 의사 결정에서 온라인 지식 자원의 역할 (Role of Online Knowledge Resources in Clinical Decision Making)

  • 무하마드 아프잘;마크불 후세인;와자하트 알리 칸;탁디르 알;이승룡
    • 한국정보처리학회:학술대회논문집
    • /
    • 한국정보처리학회 2012년도 추계학술발표대회
    • /
    • pp.450-451
    • /
    • 2012
  • The need of Clinical Decision Support System (CDSS) in healthcare setup is increasing day by day. EHR Meaningful Use advocates CDSS as an important component of EHR/EMR systems. CDSS can be ranged from a simple to a very sophisticated system. The more complex CDSS systems need more attention to develop because of many reasons including its Knowledge Base (KB) structure/maintenance/evolution, inference capabilities and usability. Above all the KB maintenance and evolution is very crucial and important from the perspective of useful decision capabilities. Also the richness of the KB is important to cover the decision gaps handling a particular situation in the course of patient care. It cannot be expected from the clinicians to remember everything in regard to patient diagnosis and treatment. Similarly, it is also crucial for clinicians to keep themselves updated with the new research in the area. That is the reason they frequently require accessing to the online knowledge resources. Literature proved that online knowledge resources are capable providing answers to questions that might not be answered rely only on clinician wisdom and experience. This paper provides the theme of meaningful utilization of online knowledge resources in the context of diagnosis and treatment process for cancer patients more specifically Head and Neck cancer.